[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f8XVeyTLESR2ukadXdRrUapAz1TXsZxnmZo3lDIV7pFY":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":8,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":32,"phaseBuckets":57,"rows":64},"Prisma Health-Upstate",[4],76,false,10,3,10983,57,[13,16,19,21,23,25,28,30],{"name":14,"count":15},"Cancer",5,{"name":17,"count":18},"Ventral Hernia",4,{"name":20,"count":18},"Hepatitis C",{"name":22,"count":9},"Opioid Use Disorder",{"name":24,"count":9},"Substance Use Disorders",{"name":26,"count":27},"Breast Neoplasm Female",2,{"name":29,"count":27},"Anxiety",{"name":31,"count":27},"Obesity",[33,38,43,48,52],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT07594717","Effects of E-Cigarette Flavors on Adult E-Cigarette Users With Opioid Use Disorder","2026-05","Sweet-cooling",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT05388929","Methocarbamol in Ventral and Inguinal HR","2026-06","Methocarbamol",{"nctId":44,"briefTitle":45,"date":46,"intervention":47},"NCT07102615","Intracervical Vasopressin","2026-08-01","Intracervical injection of Vasopressin",{"nctId":49,"briefTitle":50,"date":46,"intervention":51},"NCT07101250","Preoperative Acetazolamide","Acetazolamide 500 MG Extended Release Oral",{"nctId":53,"briefTitle":54,"date":55,"intervention":56},"NCT04039750","Use of Antibiotic Irrigation to Decrease Wound Infections in Pediatric Perforated Appendicitis","2026-12","antibiotic rinse with suction",[58,59,60,61,62,63],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[65,91,109,132,156,174,192,213,236,254,272,300,318,345,363,389,407,434,452,470,494,520,545,571,589,615,640,666,684,709,734,752,777],{"intervention":47,"totalTrials":66,"cells":67},1,{"EARLY_PHASE1":68,"PHASE1":71,"PHASE2":73,"PHASE3":75,"PHASE4":77,"NA":89},{"trials":69,"activeCount":70},[],0,{"trials":72,"activeCount":70},[],{"trials":74,"activeCount":70},[],{"trials":76,"activeCount":70},[],{"trials":78,"activeCount":66,"soonestReadout":46},[79],{"nctId":44,"briefTitle":45,"status":80,"phases":81,"primaryCompletion":46,"completion":82,"start":83,"enrollment":84,"conditions":85,"interventions":87},"RECRUITING",[62],"2026-12-01","2025-10-30",50,[86],"Retained Products of Conception",[47,88],"Intracervical Injection of saline",{"trials":90,"activeCount":70},[],{"intervention":88,"totalTrials":66,"cells":92},{"EARLY_PHASE1":93,"PHASE1":95,"PHASE2":97,"PHASE3":99,"PHASE4":101,"NA":107},{"trials":94,"activeCount":70},[],{"trials":96,"activeCount":70},[],{"trials":98,"activeCount":70},[],{"trials":100,"activeCount":70},[],{"trials":102,"activeCount":66,"soonestReadout":46},[103],{"nctId":44,"briefTitle":45,"status":80,"phases":104,"primaryCompletion":46,"completion":82,"start":83,"enrollment":84,"conditions":105,"interventions":106},[62],[86],[47,88],{"trials":108,"activeCount":70},[],{"intervention":51,"totalTrials":66,"cells":110},{"EARLY_PHASE1":111,"PHASE1":113,"PHASE2":115,"PHASE3":117,"PHASE4":119,"NA":130},{"trials":112,"activeCount":70},[],{"trials":114,"activeCount":70},[],{"trials":116,"activeCount":70},[],{"trials":118,"activeCount":70},[],{"trials":120,"activeCount":66,"soonestReadout":46},[121],{"nctId":49,"briefTitle":50,"status":80,"phases":122,"primaryCompletion":46,"completion":123,"start":83,"enrollment":124,"conditions":125,"interventions":129},[62],"2026-11-01",100,[126,127,128],"Post Operative Pain","Laparoscopic Hysterectomy","Referred Pain",[51],{"trials":131,"activeCount":70},[],{"intervention":42,"totalTrials":66,"cells":133},{"EARLY_PHASE1":134,"PHASE1":136,"PHASE2":138,"PHASE3":140,"PHASE4":142,"NA":154},{"trials":135,"activeCount":70},[],{"trials":137,"activeCount":70},[],{"trials":139,"activeCount":70},[],{"trials":141,"activeCount":70},[],{"trials":143,"activeCount":66,"soonestReadout":41},[144],{"nctId":39,"briefTitle":40,"status":145,"phases":146,"primaryCompletion":41,"completion":55,"start":147,"enrollment":148,"conditions":149,"interventions":151},"ACTIVE_NOT_RECRUITING",[62],"2022-06-23",164,[17,150],"Inguinal Hernia",[42,152,153],"Standard Opioid","Standard opioid plus methocarbamol",{"trials":155,"activeCount":70},[],{"intervention":152,"totalTrials":66,"cells":157},{"EARLY_PHASE1":158,"PHASE1":160,"PHASE2":162,"PHASE3":164,"PHASE4":166,"NA":172},{"trials":159,"activeCount":70},[],{"trials":161,"activeCount":70},[],{"trials":163,"activeCount":70},[],{"trials":165,"activeCount":70},[],{"trials":167,"activeCount":66,"soonestReadout":41},[168],{"nctId":39,"briefTitle":40,"status":145,"phases":169,"primaryCompletion":41,"completion":55,"start":147,"enrollment":148,"conditions":170,"interventions":171},[62],[17,150],[42,152,153],{"trials":173,"activeCount":70},[],{"intervention":153,"totalTrials":66,"cells":175},{"EARLY_PHASE1":176,"PHASE1":178,"PHASE2":180,"PHASE3":182,"PHASE4":184,"NA":190},{"trials":177,"activeCount":70},[],{"trials":179,"activeCount":70},[],{"trials":181,"activeCount":70},[],{"trials":183,"activeCount":70},[],{"trials":185,"activeCount":66,"soonestReadout":41},[186],{"nctId":39,"briefTitle":40,"status":145,"phases":187,"primaryCompletion":41,"completion":55,"start":147,"enrollment":148,"conditions":188,"interventions":189},[62],[17,150],[42,152,153],{"trials":191,"activeCount":70},[],{"intervention":56,"totalTrials":66,"cells":193},{"EARLY_PHASE1":194,"PHASE1":196,"PHASE2":198,"PHASE3":207,"PHASE4":209,"NA":211},{"trials":195,"activeCount":70},[],{"trials":197,"activeCount":70},[],{"trials":199,"activeCount":66,"soonestReadout":55},[200],{"nctId":53,"briefTitle":54,"status":145,"phases":201,"primaryCompletion":55,"completion":55,"start":202,"enrollment":203,"conditions":204,"interventions":206},[60],"2019-07-25",200,[205],"Perforated Appendicitis",[56],{"trials":208,"activeCount":70},[],{"trials":210,"activeCount":70},[],{"trials":212,"activeCount":70},[],{"intervention":37,"totalTrials":66,"cells":214},{"EARLY_PHASE1":215,"PHASE1":217,"PHASE2":219,"PHASE3":221,"PHASE4":223,"NA":225},{"trials":216,"activeCount":70},[],{"trials":218,"activeCount":70},[],{"trials":220,"activeCount":70},[],{"trials":222,"activeCount":70},[],{"trials":224,"activeCount":70},[],{"trials":226,"activeCount":66,"soonestReadout":36},[227],{"nctId":34,"briefTitle":35,"status":80,"phases":228,"primaryCompletion":36,"completion":36,"start":229,"enrollment":230,"conditions":231,"interventions":233},[],"2025-11-12",70,[232,22],"Nicotine Use Disoder",[37,234,235],"Sweet non-cooling EC flavor","Tobacco flavor EC",{"intervention":234,"totalTrials":66,"cells":237},{"EARLY_PHASE1":238,"PHASE1":240,"PHASE2":242,"PHASE3":244,"PHASE4":246,"NA":248},{"trials":239,"activeCount":70},[],{"trials":241,"activeCount":70},[],{"trials":243,"activeCount":70},[],{"trials":245,"activeCount":70},[],{"trials":247,"activeCount":70},[],{"trials":249,"activeCount":66,"soonestReadout":36},[250],{"nctId":34,"briefTitle":35,"status":80,"phases":251,"primaryCompletion":36,"completion":36,"start":229,"enrollment":230,"conditions":252,"interventions":253},[],[232,22],[37,234,235],{"intervention":235,"totalTrials":66,"cells":255},{"EARLY_PHASE1":256,"PHASE1":258,"PHASE2":260,"PHASE3":262,"PHASE4":264,"NA":266},{"trials":257,"activeCount":70},[],{"trials":259,"activeCount":70},[],{"trials":261,"activeCount":70},[],{"trials":263,"activeCount":70},[],{"trials":265,"activeCount":70},[],{"trials":267,"activeCount":66,"soonestReadout":36},[268],{"nctId":34,"briefTitle":35,"status":80,"phases":269,"primaryCompletion":36,"completion":36,"start":229,"enrollment":230,"conditions":270,"interventions":271},[],[232,22],[37,234,235],{"intervention":273,"totalTrials":66,"cells":274},"Amlodipine",{"EARLY_PHASE1":275,"PHASE1":277,"PHASE2":279,"PHASE3":281,"PHASE4":283,"NA":298},{"trials":276,"activeCount":70},[],{"trials":278,"activeCount":70},[],{"trials":280,"activeCount":70},[],{"trials":282,"activeCount":70},[],{"trials":284,"activeCount":70},[285],{"nctId":286,"briefTitle":287,"status":288,"phases":289,"primaryCompletion":290,"completion":291,"start":292,"enrollment":293,"conditions":294,"interventions":296},"NCT04790279","Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension","COMPLETED",[62],"2022-12-13","2023-01-25","2021-04-09",175,[295],"Hypertension in Pregnancy",[273,297],"NIFEdipine ER",{"trials":299,"activeCount":70},[],{"intervention":297,"totalTrials":66,"cells":301},{"EARLY_PHASE1":302,"PHASE1":304,"PHASE2":306,"PHASE3":308,"PHASE4":310,"NA":316},{"trials":303,"activeCount":70},[],{"trials":305,"activeCount":70},[],{"trials":307,"activeCount":70},[],{"trials":309,"activeCount":70},[],{"trials":311,"activeCount":70},[312],{"nctId":286,"briefTitle":287,"status":288,"phases":313,"primaryCompletion":290,"completion":291,"start":292,"enrollment":293,"conditions":314,"interventions":315},[62],[295],[273,297],{"trials":317,"activeCount":70},[],{"intervention":319,"totalTrials":66,"cells":320},"Mepivacaine",{"EARLY_PHASE1":321,"PHASE1":323,"PHASE2":325,"PHASE3":327,"PHASE4":329,"NA":343},{"trials":322,"activeCount":70},[],{"trials":324,"activeCount":70},[],{"trials":326,"activeCount":70},[],{"trials":328,"activeCount":70},[],{"trials":330,"activeCount":70},[331],{"nctId":332,"briefTitle":333,"status":288,"phases":334,"primaryCompletion":335,"completion":335,"start":336,"enrollment":337,"conditions":338,"interventions":341},"NCT06291727","Mepivacaine vs Bupivacaine Spinal Anesthesia for TKA",[62],"2025-08-01","2024-02-16",138,[339,340],"Anesthesia, Spinal","Arthroplasty, Replacement, Knee",[319,342],"Bupivacaine",{"trials":344,"activeCount":70},[],{"intervention":342,"totalTrials":66,"cells":346},{"EARLY_PHASE1":347,"PHASE1":349,"PHASE2":351,"PHASE3":353,"PHASE4":355,"NA":361},{"trials":348,"activeCount":70},[],{"trials":350,"activeCount":70},[],{"trials":352,"activeCount":70},[],{"trials":354,"activeCount":70},[],{"trials":356,"activeCount":70},[357],{"nctId":332,"briefTitle":333,"status":288,"phases":358,"primaryCompletion":335,"completion":335,"start":336,"enrollment":337,"conditions":359,"interventions":360},[62],[339,340],[319,342],{"trials":362,"activeCount":70},[],{"intervention":364,"totalTrials":66,"cells":365},"Liposomal bupivacaine right",{"EARLY_PHASE1":366,"PHASE1":368,"PHASE2":370,"PHASE3":372,"PHASE4":374,"NA":387},{"trials":367,"activeCount":70},[],{"trials":369,"activeCount":70},[],{"trials":371,"activeCount":70},[],{"trials":373,"activeCount":70},[],{"trials":375,"activeCount":70},[376],{"nctId":377,"briefTitle":378,"status":379,"phases":380,"primaryCompletion":381,"completion":381,"start":382,"enrollment":15,"conditions":383,"interventions":385},"NCT03383198","Pectoralis (II) Block With Liposomal Bupivacaine vs Bupivacaine for Breast Surgery","TERMINATED",[62],"2019-08-30","2017-12-01",[384],"Pain, Postoperative",[364,386],"Liposomal bupivacaine left",{"trials":388,"activeCount":70},[],{"intervention":386,"totalTrials":66,"cells":390},{"EARLY_PHASE1":391,"PHASE1":393,"PHASE2":395,"PHASE3":397,"PHASE4":399,"NA":405},{"trials":392,"activeCount":70},[],{"trials":394,"activeCount":70},[],{"trials":396,"activeCount":70},[],{"trials":398,"activeCount":70},[],{"trials":400,"activeCount":70},[401],{"nctId":377,"briefTitle":378,"status":379,"phases":402,"primaryCompletion":381,"completion":381,"start":382,"enrollment":15,"conditions":403,"interventions":404},[62],[384],[364,386],{"trials":406,"activeCount":70},[],{"intervention":408,"totalTrials":66,"cells":409},"Tropicamide",{"EARLY_PHASE1":410,"PHASE1":412,"PHASE2":414,"PHASE3":416,"PHASE4":418,"NA":432},{"trials":411,"activeCount":70},[],{"trials":413,"activeCount":70},[],{"trials":415,"activeCount":70},[],{"trials":417,"activeCount":70},[],{"trials":419,"activeCount":70},[420],{"nctId":421,"briefTitle":422,"status":288,"phases":423,"primaryCompletion":424,"completion":424,"start":425,"enrollment":426,"conditions":427,"interventions":429},"NCT05238233","Wearing-Off Period of Pharmacological Dilation and Anisocoria",[62],"2023-01-17","2022-04-01",11,[428],"Anisocoria",[408,430,431],"1% Pilocarpine","Proparacaine Hydrochloride",{"trials":433,"activeCount":70},[],{"intervention":430,"totalTrials":66,"cells":435},{"EARLY_PHASE1":436,"PHASE1":438,"PHASE2":440,"PHASE3":442,"PHASE4":444,"NA":450},{"trials":437,"activeCount":70},[],{"trials":439,"activeCount":70},[],{"trials":441,"activeCount":70},[],{"trials":443,"activeCount":70},[],{"trials":445,"activeCount":70},[446],{"nctId":421,"briefTitle":422,"status":288,"phases":447,"primaryCompletion":424,"completion":424,"start":425,"enrollment":426,"conditions":448,"interventions":449},[62],[428],[408,430,431],{"trials":451,"activeCount":70},[],{"intervention":431,"totalTrials":66,"cells":453},{"EARLY_PHASE1":454,"PHASE1":456,"PHASE2":458,"PHASE3":460,"PHASE4":462,"NA":468},{"trials":455,"activeCount":70},[],{"trials":457,"activeCount":70},[],{"trials":459,"activeCount":70},[],{"trials":461,"activeCount":70},[],{"trials":463,"activeCount":70},[464],{"nctId":421,"briefTitle":422,"status":288,"phases":465,"primaryCompletion":424,"completion":424,"start":425,"enrollment":426,"conditions":466,"interventions":467},[62],[428],[408,430,431],{"trials":469,"activeCount":70},[],{"intervention":471,"totalTrials":66,"cells":472},"Bumetanide, intranasal 4mg",{"EARLY_PHASE1":473,"PHASE1":475,"PHASE2":477,"PHASE3":479,"PHASE4":481,"NA":492},{"trials":474,"activeCount":70},[],{"trials":476,"activeCount":70},[],{"trials":478,"activeCount":70},[],{"trials":480,"activeCount":70},[],{"trials":482,"activeCount":70},[483],{"nctId":484,"briefTitle":485,"status":486,"phases":487,"primaryCompletion":488,"completion":488,"start":488,"enrollment":70,"conditions":489,"interventions":491},"NCT07375212","VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure","WITHDRAWN",[62],"2026-01-21",[490],"Heart Failure Congestive",[471],{"trials":493,"activeCount":70},[],{"intervention":495,"totalTrials":66,"cells":496},"AmnioExCel dressing and compression therapy",{"EARLY_PHASE1":497,"PHASE1":499,"PHASE2":501,"PHASE3":503,"PHASE4":505,"NA":518},{"trials":498,"activeCount":70},[],{"trials":500,"activeCount":70},[],{"trials":502,"activeCount":70},[],{"trials":504,"activeCount":70},[],{"trials":506,"activeCount":70},[507],{"nctId":508,"briefTitle":509,"status":379,"phases":510,"primaryCompletion":511,"completion":512,"start":513,"enrollment":27,"conditions":514,"interventions":517},"NCT02929056","Amniotic Membrane Allograft Application in the Management of Venous Leg Ulcerations",[62],"2018-09-06","2019-10-29","2017-02-15",[515,516],"Varicose Ulcer","Venous Insufficiency",[495],{"trials":519,"activeCount":70},[],{"intervention":521,"totalTrials":66,"cells":522},"NOMO Protocol",{"EARLY_PHASE1":523,"PHASE1":525,"PHASE2":527,"PHASE3":529,"PHASE4":541,"NA":543},{"trials":524,"activeCount":70},[],{"trials":526,"activeCount":70},[],{"trials":528,"activeCount":70},[],{"trials":530,"activeCount":70},[531],{"nctId":532,"briefTitle":533,"status":288,"phases":534,"primaryCompletion":535,"completion":536,"start":537,"enrollment":8,"conditions":538,"interventions":540},"NCT05386069","Does a Non-Opioid Multimodal Pain (NOMO) Protocol Decrease Narcotic Use",[61],"2020-12-01","2021-06-01","2019-11-15",[539],"Opioid Use",[521],{"trials":542,"activeCount":70},[],{"trials":544,"activeCount":70},[],{"intervention":546,"totalTrials":66,"cells":547},"Gemcitabine\u002F clindamycin",{"EARLY_PHASE1":548,"PHASE1":550,"PHASE2":552,"PHASE3":554,"PHASE4":567,"NA":569},{"trials":549,"activeCount":70},[],{"trials":551,"activeCount":70},[],{"trials":553,"activeCount":70},[],{"trials":555,"activeCount":70},[556],{"nctId":557,"briefTitle":558,"status":288,"phases":559,"primaryCompletion":560,"completion":560,"start":561,"enrollment":562,"conditions":563,"interventions":565},"NCT03945357","Reducing INfection at the Surgical SitE With Antibiotic Irrigation During Ventral Hernia Repair (RINSE Trial)",[61],"2023-01-09","2019-05-15",250,[564],"Ventral Hernia Repair",[546,566],"Normal saline",{"trials":568,"activeCount":70},[],{"trials":570,"activeCount":70},[],{"intervention":566,"totalTrials":66,"cells":572},{"EARLY_PHASE1":573,"PHASE1":575,"PHASE2":577,"PHASE3":579,"PHASE4":585,"NA":587},{"trials":574,"activeCount":70},[],{"trials":576,"activeCount":70},[],{"trials":578,"activeCount":70},[],{"trials":580,"activeCount":70},[581],{"nctId":557,"briefTitle":558,"status":288,"phases":582,"primaryCompletion":560,"completion":560,"start":561,"enrollment":562,"conditions":583,"interventions":584},[61],[564],[546,566],{"trials":586,"activeCount":70},[],{"trials":588,"activeCount":70},[],{"intervention":590,"totalTrials":66,"cells":591},"Ruxolitinib",{"EARLY_PHASE1":592,"PHASE1":594,"PHASE2":596,"PHASE3":609,"PHASE4":611,"NA":613},{"trials":593,"activeCount":70},[],{"trials":595,"activeCount":70},[],{"trials":597,"activeCount":70},[598],{"nctId":599,"briefTitle":600,"status":288,"phases":601,"primaryCompletion":602,"completion":535,"start":603,"enrollment":604,"conditions":605,"interventions":608},"NCT04374149","Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS",[60],"2020-09-30","2020-04-30",20,[606,607],"Cytokine Release Syndrome","COVID19",[590],{"trials":610,"activeCount":70},[],{"trials":612,"activeCount":70},[],{"trials":614,"activeCount":70},[],{"intervention":616,"totalTrials":66,"cells":617},"Melaxin (autologous dendritoma vaccine) and BCG",{"EARLY_PHASE1":618,"PHASE1":620,"PHASE2":622,"PHASE3":634,"PHASE4":636,"NA":638},{"trials":619,"activeCount":70},[],{"trials":621,"activeCount":70},[],{"trials":623,"activeCount":70},[624],{"nctId":625,"briefTitle":626,"status":379,"phases":627,"primaryCompletion":628,"completion":629,"start":630,"enrollment":9,"conditions":631,"interventions":633},"NCT00671554","Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma",[59,60],"2009-02","2009-03","2008-04",[632],"Melanoma",[616],{"trials":635,"activeCount":70},[],{"trials":637,"activeCount":70},[],{"trials":639,"activeCount":70},[],{"intervention":641,"totalTrials":66,"cells":642},"Durvalumab",{"EARLY_PHASE1":643,"PHASE1":645,"PHASE2":647,"PHASE3":660,"PHASE4":662,"NA":664},{"trials":644,"activeCount":70},[],{"trials":646,"activeCount":70},[],{"trials":648,"activeCount":70},[649],{"nctId":650,"briefTitle":651,"status":379,"phases":652,"primaryCompletion":653,"completion":653,"start":654,"enrollment":655,"conditions":656,"interventions":658},"NCT02938793","Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors",[60],"2025-09-17","2016-12-01",92,[14,657],"Rare Disease",[641,659],"Tremelimumab",{"trials":661,"activeCount":70},[],{"trials":663,"activeCount":70},[],{"trials":665,"activeCount":70},[],{"intervention":659,"totalTrials":66,"cells":667},{"EARLY_PHASE1":668,"PHASE1":670,"PHASE2":672,"PHASE3":678,"PHASE4":680,"NA":682},{"trials":669,"activeCount":70},[],{"trials":671,"activeCount":70},[],{"trials":673,"activeCount":70},[674],{"nctId":650,"briefTitle":651,"status":379,"phases":675,"primaryCompletion":653,"completion":653,"start":654,"enrollment":655,"conditions":676,"interventions":677},[60],[14,657],[641,659],{"trials":679,"activeCount":70},[],{"trials":681,"activeCount":70},[],{"trials":683,"activeCount":70},[],{"intervention":685,"totalTrials":66,"cells":686},"Tazemetostat",{"EARLY_PHASE1":687,"PHASE1":689,"PHASE2":691,"PHASE3":703,"PHASE4":705,"NA":707},{"trials":688,"activeCount":70},[],{"trials":690,"activeCount":70},[],{"trials":692,"activeCount":70},[693],{"nctId":694,"briefTitle":695,"status":379,"phases":696,"primaryCompletion":697,"completion":697,"start":698,"enrollment":604,"conditions":699,"interventions":702},"NCT05023655","Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation",[60],"2026-03-06","2022-01-06",[700,701],"Solid Tumor","ARID1A Gene Mutation",[685],{"trials":704,"activeCount":70},[],{"trials":706,"activeCount":70},[],{"trials":708,"activeCount":70},[],{"intervention":710,"totalTrials":66,"cells":711},"Famotidine",{"EARLY_PHASE1":712,"PHASE1":714,"PHASE2":726,"PHASE3":728,"PHASE4":730,"NA":732},{"trials":713,"activeCount":70},[],{"trials":715,"activeCount":70},[716],{"nctId":717,"briefTitle":718,"status":379,"phases":719,"primaryCompletion":720,"completion":720,"start":721,"enrollment":27,"conditions":722,"interventions":724},"NCT04545008","Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19",[59],"2021-06-02","2020-10-20",[723],"Covid19",[710,725],"N-Acetyl cysteine",{"trials":727,"activeCount":70},[],{"trials":729,"activeCount":70},[],{"trials":731,"activeCount":70},[],{"trials":733,"activeCount":70},[],{"intervention":725,"totalTrials":66,"cells":735},{"EARLY_PHASE1":736,"PHASE1":738,"PHASE2":744,"PHASE3":746,"PHASE4":748,"NA":750},{"trials":737,"activeCount":70},[],{"trials":739,"activeCount":70},[740],{"nctId":717,"briefTitle":718,"status":379,"phases":741,"primaryCompletion":720,"completion":720,"start":721,"enrollment":27,"conditions":742,"interventions":743},[59],[723],[710,725],{"trials":745,"activeCount":70},[],{"trials":747,"activeCount":70},[],{"trials":749,"activeCount":70},[],{"trials":751,"activeCount":70},[],{"intervention":753,"totalTrials":66,"cells":754},"Short course antibiotics",{"EARLY_PHASE1":755,"PHASE1":757,"PHASE2":759,"PHASE3":761,"PHASE4":763,"NA":765},{"trials":756,"activeCount":70},[],{"trials":758,"activeCount":70},[],{"trials":760,"activeCount":70},[],{"trials":762,"activeCount":70},[],{"trials":764,"activeCount":70},[],{"trials":766,"activeCount":70},[767],{"nctId":768,"briefTitle":769,"status":379,"phases":770,"primaryCompletion":771,"completion":771,"start":772,"enrollment":27,"conditions":773,"interventions":775},"NCT01539811","Diabetic Foot Infection Antibiotic Study",[63],"2012-04","2012-02",[774],"Diabetic Foot Infections",[753,776],"Long course antibiotics",{"intervention":776,"totalTrials":66,"cells":778},{"EARLY_PHASE1":779,"PHASE1":781,"PHASE2":783,"PHASE3":785,"PHASE4":787,"NA":789},{"trials":780,"activeCount":70},[],{"trials":782,"activeCount":70},[],{"trials":784,"activeCount":70},[],{"trials":786,"activeCount":70},[],{"trials":788,"activeCount":70},[],{"trials":790,"activeCount":70},[791],{"nctId":768,"briefTitle":769,"status":379,"phases":792,"primaryCompletion":771,"completion":771,"start":772,"enrollment":27,"conditions":793,"interventions":794},[63],[774],[753,776]]